A carregar...
Use of PCSK9 Inhibitors in Solid Organ Transplantation Recipients
Standard lipid-lowering therapies in solid organ transplantations pose challenges due to interactions with immunosuppressants. Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a new class of lipid-lowering therapies with potential promise in this population. We describe PC...
Na minha lista:
| Publicado no: | JACC Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8311616/ https://ncbi.nlm.nih.gov/pubmed/34317250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.09.026 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|